https://canvirex.com/ 2026-01-29T09:33:26Z https://canvirex.com/privacy-notice/ 2018-09-28T16:35:34Z https://canvirex.com/knowledge-base/ 2019-04-01T15:28:18Z https://canvirex.com/community/ 2019-04-01T16:34:33Z https://canvirex.com/cookie-policy/ 2024-11-28T08:06:21Z https://canvirex.com/about-canvirex/ 2023-10-06T14:41:24Z https://canvirex.com/technology/ 2020-07-02T08:15:31Z https://canvirex.com/pipeline/ 2026-01-29T09:43:59Z https://canvirex.com/team/ 2026-01-29T09:46:06Z https://canvirex.com/investor-portal/ 2024-11-28T08:12:04Z https://canvirex.com/contact-us/ 2024-11-28T08:46:53Z https://canvirex.com/technology/immuno-oncology/ 2026-01-29T09:43:11Z https://canvirex.com/technology/vaccination/ 2023-10-06T14:57:03Z https://canvirex.com/team/dr-werner-tschollar/ 2020-06-18T08:44:19Z https://canvirex.com/team/prof-dr-dr-guy-ungerechts/ 2020-06-25T17:39:14Z https://canvirex.com/team/dr-tobias-speck/ 2025-10-09T08:25:11Z https://canvirex.com/team/lic-iur-sven-hoffmann/ 2024-01-10T09:53:33Z https://canvirex.com/2020/08/04/introducing-canvirex/ 2020-08-06T16:51:40Z https://canvirex.com/news/ 2023-02-21T09:41:18Z https://canvirex.com/2020/12/12/two-sides-of-the-same-coin-measles-vectored-drugs-for-cancer-immunotherapy-and-vaccines/ 2021-02-17T13:02:57Z https://canvirex.com/2021/02/17/canvirex-in-pharma-tech-outlook-cancer-vaccination-to-activate-anti-tumor-immune-response/ 2021-02-17T13:02:40Z https://canvirex.com/team/dr-peter-stangier/ 2021-03-01T13:57:10Z https://canvirex.com/team/marcel-gremaud/ 2022-02-28T17:13:52Z https://canvirex.com/team/dr-sascha-bossow/ 2021-03-16T16:08:54Z https://canvirex.com/team/carsten-klocke/ 2021-10-20T20:57:30Z https://canvirex.com/team/peter-willinger/ 2022-03-01T08:05:01Z https://canvirex.com/2023/02/16/moving-forward-in-the-development-of-canvirexs-lead-candidate-mevacil-for-the-treatment-of-cancer/ 2023-02-21T08:54:16Z https://canvirex.com/team/alvin-lau/ 2024-02-09T13:39:50Z https://canvirex.com/privacy-statement-eu/ 2024-11-28T08:06:21Z